The two companies will work on identifying, analyzing, and understanding respiratory tract microbiome systems.
Elran Haber, CEO at Biomica Ltd, discussed the emerging role of microbiome-based treatments in cancer care.
By examining the gut-brain-microbiota axis in typical neurodevelopment, the findings could pave the way for identifying biomarkers for cognition and brain development.
The findings of a recent study shed light on why gut microbiota diversity protects against infection. The results may also inform the design of pathogen-resistant microbial communities.
Industry
Sponsored by
This partnership emerges as a strategic move to capitalize on the expanding global microbiome market.
Industry
Sponsored by
Harnessing the benefits of L. plantarum PBS067, L. rhamnosus LRH020, and B. lactis BL050 for post-menopausal symptom relief.
The findings of a recent study suggest that the crosstalk between gut microbes and the host’s immune system can influence the body’s defenses during cancer therapy.
The findings of a recent study suggest that L. reuteri eases social difficulties in autistic children.
Johan van Hylckama Vlieg, CSO and Co-founder of Freya Biosciences, discusses the latest advancements in microbial immunotherapies for women's health.
MaaT Pharma indicates completion of patient recruitment for the Phase 2a RCT Evaluating MaaT013 in combination with immune checkpoint inhibitors in metastatic melanoma.
